Enanta Pharmaceuticals v. Pfizer has been widely characterized as a case that turns on the acceptance or rejection of an alleged typographical error in a provisional patent application. That characterization is inaccurate. The alleged typographical error is a distraction that obscures the fact that the U.S. Court of Appeals for the Federal Circuit analyzed the case under the wrong legal framework. Properly understood, Enanta is not about a typo at all; rather, the dispositive question is whether the inventors possessed the invention prior to the public disclosure of the allegedly infringing compound.
This week in Other Barks & Bites: Senator Thom Tillis (R-NC) indicates that the Patent Eligibility Restoration Act’s language could be changed to address concerns about gene patents; the Seventh Circuit says that Teva plausibly alleged that Eli Lilly breached the terms of a Hatch-Waxman settlemen; and more.
In a precedential decision authored by Judge Hughes on Thursday, the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated-in-part and remanded a decision of the Court of Federal Claims that had awarded 4DD Holdings, LLC, and T4 Data Group, LLC $12,683,065.86 for the U.S. government’s infringement of their copyrighted software TETRA®. 4DD sued the Department of Defense (DOD) and the Department of Veterans Affairs (DVA) for infringement of its copyrighted software, TETRA, which served as an interoperability solution for military healthcare records stored by the two agencies in separate databases (dubbed the “Defense Medical Information Exchange (DMIX) program).
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued two decisions today affirming Patent Trial and Appeal Board (PTAB) final written decisions that found claims of three patents owned by Slingshot Printing LLC unpatentable as obvious. The rulings, issued in Slingshot Printing LLC v. Canon U.S.A., Inc., followed a set of inter partes review (IPR) proceedings that Canon U.S.A., Inc. and Canon Inc. brought against Slingshot’s printhead patents.
The mythology surrounding the act of invention tends to concentrate on the breakthrough moment. There is a flash of insight, a sketch is made on a cocktail napkin, the prototype is assembled in a garage to prove the brilliance of the concept. Unfortunately, commercial markets are considerably less romantic. They do not reward ideas merely because they are clever, patentable or even technically superior. They reward products that work, solve a problem customers recognize, can be manufactured at an economically sustainable price and generate an acceptable return for whoever assumes the risk of bringing them to market.
This week on IPWatchdog Unleashed, I spoke again with Fran Cruz, Senior Vice President of IP Solutions for Juristat. Our conversation was about a topic that should be top of mind for every patent prosecution firm, every in-house IP department, and every legal operations professional trying to make sense of the current market for patent related legal work. Where is patent prosecution work going, when does work move from firm to firm, when it does move, where is it moving, and what will firms have to do to win—or keep—the patent preparation and prosecution work?
In any patent dispute, the strength of the patent still matters. But increasingly, it is not the only thing that matters—or even, in some cases, the thing that matters most. That means where a patent dispute takes place cannot be a tactical afterthought or viewed as a choice of federal district courts in the United States alone. This is true today more than ever because despite patents ostensibly being property—at least according to the Patent Act—which tribunal and which judges make the ultimate decisions affecting the patent often matter most of all because patents and patent enforcement have become driven by ideology and the type of fervor normally reserved highly emotionally charged discussions, like religion and politics.
When the world’s best golfers descend on Royal Birkdale in Southport, England, for the 154th Open Championship, they arrive at golf’s oldest major — the tournament that has defined the sport since 1860. Played on the windswept links where the game forged its traditions, The Open has always celebrated history. But this year, it also marks the arrival of something entirely new.
Yesterday, the World Intellectual Property Organization (WIPO) published a report on the global patent landscape for generative artificial intelligence (AI) technologies showing that newly published patent families in the sector increased more during 2024 and 2025 combined than the preceding decade. While the United States has enjoyed greater annual growth rates in published patent families in the sector, six of the top 10 patenting entities are located in China, underscoring the dominant position that country is securing in an incredibly valuable and critical sector of emerging technology.
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision today in ASSA ABLOY AB v. CPC Patent Technologies Pty Ltd., affirming Patent Trial and Appeal Board (PTAB) final written decisions that upheld the validity of several claims covering a biometric access control system. ASSA ABLOY AB and its affiliates, including HID Global Corp., ASSA ABLOY Global Solutions, Inc., and Master Lock Company LLC, argued the Board misconstrued a key claim term and ignored one of its unpatentability theories, but the CAFC found neither argument persuasive.
Patent monetization is often discussed as if the hard part begins when a patent owner makes the decision to license, sell, finance, or enforce its patent assets. That is a mistake and demonstrates a lack of understanding of the difficulties and complexities of patent monetization. By the time a patent owner is sitting across the table from a potential licensee, buyer, lender, litigation funder, or accused infringer, much of the outcome has already been fully determined. The real work begins years earlier in preparation for monetization.
The United States patent system is not failing because Americans have stopped inventing. It is failing because the legal and institutional architecture built to protect invention no longer operates as a coherent innovation framework. Over time, the system has become a patchwork of overlapping tribunals, inconsistent legal standards, procedural inefficiencies, and doctrinal barriers that make it harder to obtain, defend, enforce, license, and rely upon even high-quality patent rights covering innovations of extraordinary consequence. Now in the coming months we will move forward with a candid, serious, historically grounded, and focused conversation on building—not merely patching—the next American patent system.
When I sat down with former USPTO Director Andrei Iancu for this week’s episode of IPWatchdog Unleashed, I expected a serious conversation about the condition of the U.S. patent system. Instead of rehashing everything that has gone wrong with the U.S. patent system from the perspective of an innovator over the last two decades, what took place was a deep and revealing conversation about whether the legal architecture that once made the United States the world’s innovation leader is still fit for purpose in an economy increasingly defined by software, artificial intelligence, data, biotechnology, and other intangible assets.
This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.
Get Email Updates